Stocks were mixed at midday Monday as Merck weighed on the Dow and tech strength boosted the Nasdaq.
Amid reports that CVS Health is in discussions to purchase health insurance giant Aetna for $66 billion, TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer thinks regulators would approve such a deal.
TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer doesn't advise panicking over Celgene.
Pfizer is reportedly planning to sell its consumer healthcare business in an auction next month
TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer said Eli Lilly LLY had a good quarter but the stock is getting hit by a rotation, as opposed to its specific performance.
Top stories today: Eli Lilly is raising its projections for the entire year since its newer drugs are doing well, Sears stops selling Whirlpool appliances in their stores and President Trump meets with lawmakers to discuss tax reform.
Famed television host Dr. Oz supports Amazon's potential move into the pharmacy business, pointing to the company's track record of lowering prices for consumers.
Schlumberger shares are down 25% since the start of the year.
Shares of Gilead Sciences rose 2% Thursday after the FDA approved its Yescarta lymphoma cancer therapy drug.
Today's Top Stories: Amazon's deadline to submit a proposal to build a new headquarters is today, Gilead shares are jumping as a result of the FDA's approval of a cancer treatment, today marks the 30th anniversary of Black Monday.